Report Code: A02376 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Tissue Diagnostics Market
Request Now !Tissue diagnostics involves removal of tissue (at a micro level) from the patient’s body, which is then processed, analyzed, and tested under the microscope to detect diseases such as cancer. Advancements in the techniques and equipment of tissue diagnostics helps for fast and accurate determination and evaluation of diseases related to the tissues.
Rise in incidences of cancer, rapid increase in aging population, and growth in healthcare expenditure drive the market. However, budget constraints and high degree of consolidation restrain the market growth. In addition, emerging markets and increased use of personalized medicine offer lucrative opportunities for the market growth.
The report segments the tissue diagnostic market on the basis of product, disease, technology, end user, and region. Based on the product, the market is bifurcated into consumables and instruments. Based on diseases, it is classified into breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and others. Based on technology, it is categorized into immunohistochemistry (IHC), situ hybridization (ISH), digital pathology & workflow management, and special staining. Based on end users, the market is divided into hospitals, research laboratories, pharmaceutical companies, contract research organizations, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players of tissue diagnostics market are Abbott Laboratories, Inc., Agilent Technologies, Inc., Biogenex Laboratories, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman-La Roche AG, Sakura Finetek Japan Co., Ltd., Sigma-Aldrich Corporation, Thermo Fisher Scientific, and Bio Sb.
Key Benefits
Tissue Diagnostics Market Report Highlights
Aspects | Details |
---|---|
By Product |
|
By Disease |
|
By Technology |
|
By End User |
|
By Region |
|
Key Market Players | Thermo Fisher Scientific, Biogenex Laboratories, Bio Sb, Danaher Corporation, F. Hoffman-La Roche AG, Agilent Technologies, Inc., Sakura Finetek Japan Co., Ltd., Cell Signaling Technology, Inc., Sigma-Aldrich Corporation, Abbott Laboratories, Inc. |
Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers